431 related articles for article (PubMed ID: 36300959)
21. Longitudinal Bile Acid Composition Changes Following Faecal Microbiota Transplantation for Clostridioides difficile Infection in Children With and Without Underlying Inflammatory Bowel Disease.
Chen LA; Oliva-Hemker M; Radin A; Weidner M; O'Laughlin BD; Sears CL; Javitt NB; Hourigan SK
J Crohns Colitis; 2023 Aug; 17(8):1364-1368. PubMed ID: 36988432
[TBL] [Abstract][Full Text] [Related]
22. Diagnosis and management of Clostridioides difficile infection in patients with inflammatory bowel disease.
Dalal RS; Allegretti JR
Curr Opin Gastroenterol; 2021 Jul; 37(4):336-343. PubMed ID: 33654015
[TBL] [Abstract][Full Text] [Related]
23. Longitudinal microbiome analysis of single donor fecal microbiota transplantation in patients with recurrent Clostridium difficile infection and/or ulcerative colitis.
Mintz M; Khair S; Grewal S; LaComb JF; Park J; Channer B; Rajapakse R; Bucobo JC; Buscaglia JM; Monzur F; Chawla A; Yang J; Robertson CE; Frank DN; Li E
PLoS One; 2018; 13(1):e0190997. PubMed ID: 29385143
[TBL] [Abstract][Full Text] [Related]
24. Clostridium difficile in inflammatory bowel disease.
Alhobayb T; Ciorba MA
Curr Opin Gastroenterol; 2023 Jul; 39(4):257-262. PubMed ID: 37265220
[TBL] [Abstract][Full Text] [Related]
25. The interplay of gut microbiota between donors and recipients determines the efficacy of fecal microbiota transplantation.
He R; Li P; Wang J; Cui B; Zhang F; Zhao F
Gut Microbes; 2022; 14(1):2100197. PubMed ID: 35854629
[TBL] [Abstract][Full Text] [Related]
26. Treatment of recurrent Clostridium difficile infection using fecal microbiota transplantation in patients with inflammatory bowel disease.
Newman KM; Rank KM; Vaughn BP; Khoruts A
Gut Microbes; 2017 May; 8(3):303-309. PubMed ID: 28102756
[TBL] [Abstract][Full Text] [Related]
27. Fecal microbiota transplantation as a new therapy: from Clostridioides difficile infection to inflammatory bowel disease, irritable bowel syndrome, and colon cancer.
Borody TJ; Eslick GD; Clancy RL
Curr Opin Pharmacol; 2019 Dec; 49():43-51. PubMed ID: 31173991
[TBL] [Abstract][Full Text] [Related]
28. Systematic Review with Meta-Analysis: Fecal Microbiota Transplantation for Severe or Fulminant Clostridioides difficile.
Tixier EN; Verheyen E; Luo Y; Grinspan LT; Du CH; Ungaro RC; Walsh S; Grinspan AM
Dig Dis Sci; 2022 Mar; 67(3):978-988. PubMed ID: 33748913
[TBL] [Abstract][Full Text] [Related]
29. Intestinal microbiota, fecal microbiota transplantation, and inflammatory bowel disease.
Weingarden AR; Vaughn BP
Gut Microbes; 2017 May; 8(3):238-252. PubMed ID: 28609251
[TBL] [Abstract][Full Text] [Related]
30. Any Future for Fecal Microbiota Transplantation as Treatment Strategy for Inflammatory Bowel Diseases?
Kump P; Högenauer C
Dig Dis; 2016; 34 Suppl 1():74-81. PubMed ID: 27548724
[TBL] [Abstract][Full Text] [Related]
31. Effectiveness and Safety of Colonic and Capsule Fecal Microbiota Transplantation for Recurrent Clostridioides difficile Infection.
Vaughn BP; Fischer M; Kelly CR; Allegretti JR; Graiziger C; Thomas J; McClure E; Kabage AJ; Khoruts A
Clin Gastroenterol Hepatol; 2023 May; 21(5):1330-1337.e2. PubMed ID: 36126907
[TBL] [Abstract][Full Text] [Related]
32. Fecal microbiota transplantation for the treatment of patients with ulcerative colitis and other gastrointestinal conditions beyond Clostridium difficile infection: an update.
Holleran G; Scaldaferri F; Ianiro G; Lopetuso L; Mc Namara D; Mele MC; Gasbarrini A; Cammarota G
Drugs Today (Barc); 2018 Feb; 54(2):123-136. PubMed ID: 29637938
[TBL] [Abstract][Full Text] [Related]
33. Clostridioides difficile infection in inflammatory bowel disease: a clinical review.
Tang M; Wang C; Xia Y; Tang J; Wang J; Shen L
Expert Rev Anti Infect Ther; 2024 May; 22(5):297-306. PubMed ID: 38676422
[TBL] [Abstract][Full Text] [Related]
34. The Current Landscape and Lessons from Fecal Microbiota Transplantation for Inflammatory Bowel Disease: Past, Present, and Future.
Allegretti J; Eysenbach LM; El-Nachef N; Fischer M; Kelly C; Kassam Z
Inflamm Bowel Dis; 2017 Oct; 23(10):1710-1717. PubMed ID: 28858073
[TBL] [Abstract][Full Text] [Related]
35. Application and development of fecal microbiota transplantation in the treatment of gastrointestinal and metabolic diseases: A review.
Mahmoudi H; Hossainpour H
Saudi J Gastroenterol; 2023; 29(1):3-11. PubMed ID: 36412458
[TBL] [Abstract][Full Text] [Related]
36. Predictors and Management of Failed Fecal Microbiota Transplantation for Recurrent Clostridioides difficile Infection.
Tariq R; Saha S; Solanky D; Pardi DS; Khanna S
J Clin Gastroenterol; 2021 Jul; 55(6):542-547. PubMed ID: 32701563
[TBL] [Abstract][Full Text] [Related]
37. Fecal Microbiota Transplantation for Clostridioides difficile in High-Risk Older Adults Is Associated with Early Recurrence.
Luo Y; Tixier EN; Grinspan AM
Dig Dis Sci; 2020 Dec; 65(12):3647-3651. PubMed ID: 32078714
[TBL] [Abstract][Full Text] [Related]
38. The risk of inflammatory bowel disease flares after fecal microbiota transplantation: Systematic review and meta-analysis.
Qazi T; Amaratunga T; Barnes EL; Fischer M; Kassam Z; Allegretti JR
Gut Microbes; 2017 Nov; 8(6):574-588. PubMed ID: 28723262
[TBL] [Abstract][Full Text] [Related]
39. Fecal Microbiota Transplantation for Treatment of Severe Clostridioides difficile Colitis in a Pediatric Patient With Non-Hodgkin Lymphoma.
Sabus A; Merrow M; Heiden A; Boster J; Koo J; Franklin ARK
J Pediatr Hematol Oncol; 2021 Aug; 43(6):e897-e899. PubMed ID: 33273413
[TBL] [Abstract][Full Text] [Related]
40. Autologous fecal microbiota transplantation for the treatment of inflammatory bowel disease.
Basson AR; Zhou Y; Seo B; Rodriguez-Palacios A; Cominelli F
Transl Res; 2020 Dec; 226():1-11. PubMed ID: 32585148
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
